On May 29, 2025, Cero Therapeutics Holdings, Inc. announced that its stockholders approved an amendment to increase shares available under its Equity Incentive Plan by 2,000,000 shares, and authorized a reverse stock split of 1-for-20 effective June 10, 2025.